| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:J 104129 fuMarate;(αR)-α-Cyclopentyl-α-hydroxy-N-[1-(4-Methyl-3-pentenyl)-4-piperidinyl]benzeneacetaMidefuMarate CAS:244277-89-2 Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
(AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE manufacturers
|
| | (AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE Basic information |
| | (AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE Chemical Properties |
| storage temp. | Store at +4°C | | solubility | <50.06mg/ml in DMSO; <25.03mg/ml in ethanol |
| | (AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE Usage And Synthesis |
| Uses | J 104129 is a mAChR M3 antagonist. | | Biological Activity | Potent M 3 muscarinic receptor antagonist that displays ~ 120-fold selectivity over M 2 receptors (K i values are 4.2, 19 and 490 nM for human M 3 , M 1 and M 2 receptors respectively). Exhibits > 250-fold bronchial selectivity; inhibits ACh-induced bronchoconstriction but not ACh-induced bradycardia (K B values are 3.3 and 170 nM for rat trachea M 3 and rat right atria M 2 receptors respectively). | | in vivo | J-104129 (10 mg/kg; p.o.; single) shows durable bronchodilatory action lasting over 10 h in rats[1][2].
J-104129 (p.o.) antagonizes ACh-induced bronchoconstriction with an ED50 value of 0.58 mg/kg in rats[1]. | Animal Model: | Male Sprague-Dawley rats[1][2]. | | Dosage: | 10 mg/kg | | Administration: | Oral administration; single. | | Result: | Exhibited bronchodilatory activity. |
|
| | (AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE Preparation Products And Raw materials |
|